logo

Aquestive Therapeutics Inc. (AQST)



Trade AQST now with
  Date
  Headline
7/11/2022 8:20:29 AM Aquestive Therapeutics Reports Positive Results From Final Two Arms Of EPIPHAST Trial
4/13/2022 8:09:30 AM Aquestive Therapeutics Announces Common Stock Purchase Agreement For Up To $40 Million With Lincoln Park Capital
3/10/2022 10:31:26 AM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) FY 22 Rev. Estimate To 46.5 M From 57.7 M
3/10/2022 10:31:08 AM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) Q4 22 Rev. Estimate To 14.1 M From 20.3 M
3/10/2022 10:30:57 AM Wedbush Is Cutting Aquestive Therapeutics Inc. (AQST) Q3 22 Rev. Estimate To 12.4 M From 16.3 M
3/10/2022 10:30:46 AM Wedbush Is Cutting Aquestive Therapeutics Inc. (AQST) Q2 22 Rev. Estimate To 10.7 M From 11.9 M
3/10/2022 10:30:34 AM Wedbush Is Raising Aquestive Therapeutics Inc. (AQST) Q1 22 Rev. Estimate To 9.3 M From 9.1 M
3/10/2022 10:30:12 AM Wedbush Is Cutting Aquestive Therapeutics Inc. (AQST) FY 22 Estimate To -1.41 From -1.27
3/10/2022 10:29:56 AM Wedbush Is Cutting Aquestive Therapeutics Inc. (AQST) Q4 22 Estimate To -0.24 From -0.13
3/10/2022 10:29:42 AM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) Q3 22 Estimate To -0.35 From -0.30
3/10/2022 10:29:07 AM Wedbush Reiterates Aquestive Therapeutics Inc. (AQST) At Outperform With $8 Down From $26 Price Target
12/22/2021 4:51:24 PM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) FY22 Rev. Estimate To 57.7 M From 68.4 M
12/22/2021 4:51:08 PM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) Q4 22 Rev. Estimate To 20.3 M From 22.9 M
12/22/2021 4:50:51 PM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) Q3 22 Rev. Estimate To 16.3 M From 18.4 M
12/22/2021 4:50:36 PM Wedbush Is Cutting Aquestive Therapeutics Inc. (AQST) Q2 22 Rev. Estimate To 11.9 M From 15.0 M
12/22/2021 4:50:22 PM Wedbush Is Cutting Aquestive Therapeutics Inc. (AQST) Q1 22 Rev. Estimate To 9.1 M From 12.1 M
12/22/2021 4:49:46 PM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) FY22 Estimate To -1.27 From -1.01